Diabetic neuropathy occurs in more than 60% of diabetic's populations. The aim of our study wasto describe clinical and electromyography characteristics of diabetic neuropathy in a Senegalese black diabetic population (Senegal). This was a cross-sectional study of 68 neuropathic type 2 diabetic patients with 56.8years mean age. Clinical examination, Visual Analog Scale, Neuropathy Symptom Score, Disability Neuropathy Score and electro neuromyography were used to characterize neuropathy. Mean duration of diabetes was 8.7 years and mean glycosylated hemoglobin9%. Motor neuron deficit was found in one patient. The main sensory disorders were paresthesia (97%), neuropathic pain (94%), and hyperesthesia (44%). Cramps were found in 45.5% and tendon reflex abnormalities in 63.2% of cases. Tachycardia (52.9%), intestinal transit disorders (42.6%) were the most common symptom of autonomic nervous system neuropathy. High blood pressure (p=0.05) and sex (p<0.001) were statistically associated with autonomic nervous system neuropathy. The electro neuromyography (EMG) showed axonal sensorimotor neuropathy (50.7%), demyelinating sensorimotor neuropathy (70%), axonal damage (27%) and myelin damage (20.6%). Axonal neuropathy was statistically correlated to diabetes' treatment (p<0.001) and demyelinating neuropathy with diabetes follow-up. Peripheral neuropathy was the most common type of polyneuropathy (42.6%). The EMG abnormalities were not statistically correlated with duration of diabetes and glycosylated hemoglobin (p>0.05). Diabetic neuropathy in our series is a multi variate symptom with usually mixed type. Its risks' factors were still poorly known. Studies on larger series would better characterize it.
Introduction
Diabete mellitus is a public health problem essentially due to degenerative complications [Gning SB, 2007; Drabo YJ, 1996] . Neuropathy is a diabetic degenerative nervous system complication with a prevalence variable based on criteria definition [Said G, 2002] . It occurs in more than 60% of diabetic patients [Lu B, 2010] . Diabetic duration, chronic hyperglycemia [Tomlinson DR, 2008] and hypertension [Tesfaye S, 2005] are the main important risks factors of onset and worsening diabetic neuropathy. Electrophysiological characteristics of diabetic neuropathy are poorly described in sub-Saharan Africa population. Objective of this study was to describe clinical and electromyographic features of diabetic neuropathy in black population as well as its risks factors in the University Hospital center of Dakar (Senegal).
Materials and Methods
This was a cross-sectional, descriptive and analytical study conducted from 1 October 2012 to 31 May 2013 at Marc Sankalé Diabetes Center, neurological center of Fan hospital Dakar and physiological center of University Hospital center of Dakar. In first step, all patients consulted during studies' period were included. In a second step, type 1 diabetics, young less than 18 years, pregnant or breastfeeding women, and those using neuro protective agents were excluded. All patients with clinical or laboratory evidences conditions that may cause neuropathy like anemia, renal failure, inflammatory diseases, other metabolic and nutritional disorders, toxic or drug agent were excluded. Final outcome was a series of 68 type 2 diabetes patients over age of 18 years, without all others causes of neuropathy, consenting to the study and presenting clinical diagnosis of diabetic neuropathy. The following data were collected in our patients:
Socio-demographic and anthropometric data; Data about diabetes: duration period, diabetes control level by glycosylated hemoglobin (HbA1c), ongoing treatment and follow up Clinical assessment: Clinical examination particularity neurological, Visual Analog Scale (EVA) [Jensen MP, 1986] , Neuropathy Symptom Score (NSS) [Meijer JWG, 2002] and Neuropathy Disability Score (NDS) [Boulton, 2005] Bergh PY, 2010] . Demyelinating neuropathy was defined based on a decrease in conduction velocity in at least two different nerves ≥30% of the lower limit of normal axonal. The axonal damage is manifested by a decrease in potential amplitude. Mixed axonal and demyelinating was defined based on axonal and demyelinating manifestations.
The 8 th Joint National Committee criteria [James PA, 2014] and International Obesity Task Force classification [Cole TJ, 2000] were used to distribute patients based on blood pressure level and body mass index. A heart rate ≤ 60 beats per minute was defined as Bradycardia and tachycardia was defined as a heart rate ≥ 100 beats per minute. Orthostatic hypotension was defined as reduction of at least 20 mmHg of systolic blood pressure and/or 10 mmHg in diastolic blood pressure after 2 minutes with a shifting from a sitting position to a standing [The consensus committee of the American autonomic society and the American academy of neurology, 1996]. For descriptive analysis, data were presented as percentage for qualitative variables and means with standard deviation for quantitative variables. We used chi-2 test for qualitative variables and Student for quantitative variables. A p < 0.05 was considered statistically significant with confidence interval 95%. Data analysis was done by SPSS 18.0 software.
Results
We studied sixty-eight (68) patients with diabetic neuropathy. Sex ratio (M/F) was 0.38, mean age 56.8±12 years (range 21 to 76 years) and 42.6% were older than 60 years.
Diabetes Mellitus Studies
Mean duration of diabetes was 8.7±6 years (38.2%≤ 5 years, 26.4% between 6 and 10 years and 37.4% greater than 10 years). High blood pressure was found in 86.1%, obesity 51.4%of which 42.6%were in overweight. Other risk factors were smoking 1.4%, alcoholism 3.4%. Drinking coffee and tea represented 76.4% and 55.8% respectively. Treatment of diabetes was oral anti diabetic (48.5%), insulin therapy (33.8%) and only dietary (17.6%). At baseline, mean HbA1c was 9% (range 6.3% to 16.5%). Level of HbA1c was least than 7% in 4.4%, between 7% and 10% in 58.8% and up to 10% in 36.7%.
Clinical Study of Diabetic Neuropathy
In our study population, motor deficit concern one patient (1.4%) particularly a weakness of quadriceps muscle. Sensory disorders such as paresthesia are found in 97% of cases.
These sensory involvement were statistically related to pain intensity according to Visual Analogue Scale (p=0.02). Muscle cramps concerned 45.5% of patients, tendon reflex abnormalities 63.2% of cases and dominated by Achilles reflex disorders. Table I shows different types of neurological manifestations. The Neuropathy Symptom Score (NSS) found mild (13.2%), moderate (60.2%) and severe neurological symptoms (26.4%). Neurological pain assessed by Visual Analogue Scale found 58.8% moderate pain, 35.2% severe pain and 5.8% mild pain. These pain were only correlated to sensitives abnormalities (p=0.022).
Regarding to autonomic nervous system neuropathy, tachycardia concerned 52.9%, bowel transit abnormalities 42.6% and erectile dysfunction 20.6% of cases. Electrocardiography performed in all patients had not shown any signs indicating myocardial ischemia. High blood pressure was statistically correlated with occurrence of autonomic nervous system disorders (p=0.05), as well as the sex (p<0.001). However, HbA1c level, diabetes treatment method and body mass index was not statistically correlated with neurological disorders observed on physical examination (p>0.05).
Electromyographic Characteristics
Electromyographic examination was normal in 7.3% (5 patients) of our patients although effectives abnormalities in physical examination. Concerning these 5 patients, it was about sensory disorders in all, absence of Achilles' tendon reflex in 4 cases, autonomic nervous system disorders in 2 patients and motor disorders as muscular atrophy in 2 patients. Electromyographic abnormalities as axonal and demyelinating sensorimotor neuropathy were noted in 50.7% of cases. Regarding electromyographic abnormalities, 70% of them concerned sensorimotor neuropathy. Axonal damage was seen in 27%, among them 6.3% had sensory neuropathies, 6.3% motor neuropathy and 15.8% mixed sensorimotor. Demyelinated represented 20.6% of patients. Axonal neuropathy was statistically correlated with patient's treatment (p<0.001) and demyelinating neuropathy with their follow up. Polyneuropathy found in 42.6% of cases, was the most common type of neuropathy in our diabetic. We did not find any statistical correlation between EMG abnormalities and duration of diabetes, HbA1c level (p > 0.05).
Discussion
Mean agein our series was similar to reported by Adoukonou et al., [Adoukonou TA, 2008] but with short lasted diabetes and poorly controlled diabetes. These last two parameters were of 15 years and 7.9% respectively in this french series [Adoukonou TA, 2008] . Therapeutic and scalable glycemic profile is consistent with data of Partanen et al., [Partanen J, 1995] .
Clinically, prevalence of neuropathic pain up to 71.4% is constant worldly [Adoukonou TA, 2008; Sharma KS, 2008; Argoff C, 2006] . In our study the VAS pain score found severe, moderate and light neuropathic pain in 35.2%, 58.8% and 5.8% respectively. Sensory disorders seem to be the most common [Adoukonou TA, 2008] . The special feature of our study is the low rate of motor damage. It was reported 10% by Adoukonou et al., [Adoukonou TA, 2008] . According to some authors, this low rate is due to the fact that these abnormalities go unnoticed in clinical examination or sometimes reduced to a discrete level in the territory of neuralgia [Gautier JF, 1997] . Autonomic neuropathy was observed in 80% by Kim et al. , [Kim SK, 2012] . In our study, tachycardia due to parasympathetic nerve involvement was dominant. It is the initial phase of autonomic heart disease [Rundles RW, 1945] .
Achilles tendon reflex abnormalities were the most common tendon reflex abnormality reported and almost always bilateral. However, the patellar reflex is less common involved and other tendon reflexes are generally normal [Gautier JF, 1997] . Whatever the type of neuropathy, the risks of trophic disorders occurrence such as plantar hyperkeratosis is important and must be prevented by patient's education [Pirart J, 1997] . Furthermore, the role of nociceptive perceptions impairment and demyelinated nerve fibers inflammation in diabetic neuropathy with trophic disturbance has been showed [Park house N, 1988] .
Clinical an electric contrast in our five 5 patients can be explain by limits for conventional electroneuromyography to explore small sensitive fibers. Diabetic neuropathy starts with the involvement of small non-myelinated fibers responsible for burning feet and paresthesia. EMG may become positive only after involvement of large myelinated fibers [Adoukonou TA, 2008] . A prevalence of sensorimotor neuropathy at 70% was already reported by Gautier et al. , [Gautier JF, 1997] . We report a predominance of axonal forms (27%) comparing to demyelinating neuropathy (20.6%). Our finding does not conform to Adoukonou et al., [Adoukonou TA, 2008] find in which demyelinating neuropathies concern 30% of patients, far more frequent than the axonal neuropathies.
It is showed that peripheral polyneuropathy is the most common type of diabetic neuropathy that can be found in up to 90% of cases [Gautier JF, 1997] . It is typically chronic, bilateral and symmetrical sensorimotor neuropathy [Dyck PJ, 1993] . In our series, the electromyographic features of neuropathy did not correlate to diabetes characteristics such as HbA1 clevel and duration of diabetes. The types of peripheral neuropathies and their clinical presentations are diverse and varied [Tesfaye S, 2010] . The possible role of immunity and individual susceptibility however, should not be clipped [Rajabally AY, 2004; Krendel DA, 1995] .
Conclusion
Screening for peripheral neuropathy is part of the yearly diabetic control. Sometime it is important to characterize diabetic neuropathy on the electrophysiological especially for atypical forms. Although good diabetes control remains decisive therapeutically but does not always improve symptoms; hence the needs for a multidisciplinary approach integrating the neurologist. The determining factors of diabetic neuropathy remain poorly understood. Future studies may help to better characterize diabetic neuropathies and factors associated with them.
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